Many thyroid cancer survivors cite inadequate pretreatment understanding

by Elana Gotkine HealthDay ReporterA considerable proportion of survivors of thyroid cancer report inadequate pretreatment understanding, according to a study published online Dec. 29 inJAMA Oto

Updated on: January 15,2024

Many thyroid cancer survivors cite inadequate pretreatment understanding

by Elana Gotkine HealthDay ReporterA considerable proportion of survivors of thyroid cancer report inadequate pretreatment understanding, according to a study published online Dec. 29 inJAMA Oto

Updated on:January 15,2024

New tool helps find genetic culprits in cancer's spread

by Bill Hathaway,Yale UniversityYale researchers developed a new approach to simultaneously investigate hundreds of mutation combinations for their ability to drive lung metastasis. Credit: Yale

Updated on: March 01,2024

New tool helps find genetic culprits in cancer's spread

by Bill Hathaway,Yale UniversityYale researchers developed a new approach to simultaneously investigate hundreds of mutation combinations for their ability to drive lung metastasis. Credit: Yale

Updated on:March 01,2024

Researchers discover how bowel cancer 'blinds' the immune system

by University of GlasgowCredit: AI-generated imageA mystery which has stumped bowel cancer researchers for decades, has been solved by scientists at the Cancer Research UK Beatson Institute and U

Updated on: February 01,2024

Researchers discover how bowel cancer 'blinds' the immune system

by University of GlasgowCredit: AI-generated imageA mystery which has stumped bowel cancer researchers for decades, has been solved by scientists at the Cancer Research UK Beatson Institute and U

Updated on:February 01,2024

Study reveals extent of residual lung damage after COVID-19 hospitalization

by American Thoracic SocietyNew study finds up to 11 percent of patients had lung scarring after COVID-19 infection that may get worse over time. Credit: ATSIn a new study published online in the

Updated on: February 01,2024

Study reveals extent of residual lung damage after COVID-19 hospitalization

by American Thoracic SocietyNew study finds up to 11 percent of patients had lung scarring after COVID-19 infection that may get worse over time. Credit: ATSIn a new study published online in the

Updated on:February 01,2024

A CAR T cell therapy for advanced ovarian cancer developed

by City of Hope National Medical CenterMembrane-bound IL-12 engineered TAG72-CAR T cells induce higher IFNγ, T-cell expansion, and anti-tumor activity in vitro.a–cTumor cell killing o

Updated on: February 18,2024

A CAR T cell therapy for advanced ovarian cancer developed

by City of Hope National Medical CenterMembrane-bound IL-12 engineered TAG72-CAR T cells induce higher IFNγ, T-cell expansion, and anti-tumor activity in vitro.a–cTumor cell killing o

Updated on:February 18,2024

Study finds 5-year relative survival rate of 59.6 percent in lower-risk myelodysplastic syndromes

by Elana Gotkine HealthDay ReporterAbout 40 percent of patients with lower-risk myelodysplastic syndromes (LR-MDS) die of MDS within five years, according to a study published online Nov. 6 in the&nbs

Updated on: January 23,2024

Study finds 5-year relative survival rate of 59.6 percent in lower-risk myelodysplastic syndromes

by Elana Gotkine HealthDay ReporterAbout 40 percent of patients with lower-risk myelodysplastic syndromes (LR-MDS) die of MDS within five years, according to a study published online Nov. 6 in the&nbs

Updated on:January 23,2024

Spiritual themes, distrust may factor into Black patients' reluctance to participate in cancer clinical trials

byAmerican Society for Radiation OncologyCredit: CC0 Public DomainSpiritual beliefs and a historically-based distrust of clinical research may factor into Black patients' decisions about whe

Updated on: October 22,2024

Spiritual themes, distrust may factor into Black patients' reluctance to participate in cancer clinical trials

byAmerican Society for Radiation OncologyCredit: CC0 Public DomainSpiritual beliefs and a historically-based distrust of clinical research may factor into Black patients' decisions about whe

Updated on:October 22,2024

Treatment found to reduce progression of rare blood cancer by 74%

Credit: Wikimedia CommonsA treatment that involves genetically modifying the body's own immune cells has been found to cut the risk of disease progression by 74 percent in people with a rare type

Updated on: January 29,2024

Treatment found to reduce progression of rare blood cancer by 74%

Credit: Wikimedia CommonsA treatment that involves genetically modifying the body's own immune cells has been found to cut the risk of disease progression by 74 percent in people with a rare type

Updated on:January 29,2024

Breast cancer survivors can safely interrupt therapy during pregnancy: study

by Amy NortonFor young women who survive breast cancer, a new study offers some reassurance about pregnancy: Pausing hormonal therapy to have a baby does not raise the risk of a cancer recurrence, at

Updated on: February 18,2024

Breast cancer survivors can safely interrupt therapy during pregnancy: study

by Amy NortonFor young women who survive breast cancer, a new study offers some reassurance about pregnancy: Pausing hormonal therapy to have a baby does not raise the risk of a cancer recurrence, at

Updated on:February 18,2024

Ethnic diversity and disparities in access to genetic testing impact prostate cancer development and treatment

byEuropean Society for Medical OncologyCredit: Unsplash/CC0 Public DomainMore than 1.4 million men were diagnosed with prostate cancer in 2020 globally, but the molecular characteristics of the

Updated on: January 22,2024

Ethnic diversity and disparities in access to genetic testing impact prostate cancer development and treatment

byEuropean Society for Medical OncologyCredit: Unsplash/CC0 Public DomainMore than 1.4 million men were diagnosed with prostate cancer in 2020 globally, but the molecular characteristics of the

Updated on:January 22,2024

Researchers develop AI platform to rapidly identify optimal personalised drug combinations for myeloma patients

by National University of SingaporeA multidisciplinary team of researchers from NUShas developed an AI technology platform that could enable doctors to prescribe personalised treatments for

Updated on: June 08,2024

Researchers develop AI platform to rapidly identify optimal personalised drug combinations for myeloma patients

by National University of SingaporeA multidisciplinary team of researchers from NUShas developed an AI technology platform that could enable doctors to prescribe personalised treatments for

Updated on:June 08,2024

Novel immunotherapy agent safe, shows promise against high-risk prostate cancers

byJohns Hopkins University School of MedicinePatient consort diagram and efficacy outcomes in the neoadjuvant treatment of patients with PCa using enoblituzumab. Credit:Nature Medicine&nbs

Updated on: January 15,2024

Novel immunotherapy agent safe, shows promise against high-risk prostate cancers

byJohns Hopkins University School of MedicinePatient consort diagram and efficacy outcomes in the neoadjuvant treatment of patients with PCa using enoblituzumab. Credit:Nature Medicine&nbs

Updated on:January 15,2024